The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure. (Q53621468)

16 May 2018

title

The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure. (English)

1 reference

16 May 2018

0 references

1 reference

Serkan Ozturk

1 reference

16 May 2018

Selçuk Öztürk

1 reference

16 May 2018

Fatma Hizal Erdem

1 reference

16 May 2018

Alim Erdem

1 reference

16 May 2018

Selim Ayhan

1 reference

16 May 2018

İbrahim Dönmez

1 reference

16 May 2018

Mehmet Yazıcı

1 reference

16 May 2018

publication date

2 April 2016

1 reference

16 May 2018

Journal of Interventional Cardiac Electrophysiology

published in

1 reference

16 May 2018

volume

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

253-258

1 reference

16 May 2018

Predictors of mortality and morbidity in patients with chronic heart failure

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

The biological effects of ivabradine in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Ivabradine: an intelligent drug for the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Measurement of funny current (I(f)) channel mRNA in human atrial tissue: correlation with left atrial filling pressure and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Left atrial function in heart failure with impaired and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Left atrial Frank-Starling law assessed by real-time, three-dimensional echocardiographic left atrial volume changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Relationships of the appropriateness of left ventricular mass to left atrial size and function in arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-016-0129-2

Characterization of the hyperpolarization-activated inward current in isolated human atrial myocytes

21 January 2018

1 reference

12 December 2020

Increasing degrees of left ventricular filling impairment modulate left atrial function in humans

1 reference

12 December 2020

Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation

1 reference

12 December 2020

Introduction to atrial fibrillation and heart failure: a mutually noxious association

1 reference

12 December 2020

Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation

1 reference

12 December 2020

Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery

1 reference

12 December 2020

Electrophysiological effects of ivabradine in dog and human cardiac preparations: Potential antiarrhythmic actions

1 reference

12 December 2020

Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation

1 reference

12 December 2020

10.1007/S10840-016-0129-2

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018